KRBP LAWSUIT: Hagens Berman, National Trial Attorneys, Encourages Kiromic BioPharma (KRBP) Investors with Significant Losses to ...
SAN FRANCISCO, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Kiromic BioPharma, Inc. KRBP investors who purchased Kiromic shares to submit your losses now. Class Period: June 25, 2021 – Aug. 13, 2021 Lead Plaintiff Deadline: Oct. 4, 2022 Visit: …